Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 26 July 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

The problem of Helicobacter pylori resistance to antibiotics

This month's issue of the American Journal of Gastroenterology reports on the problem of Helicobacter pylori resistance to antibiotics in Latin America.

News image

Latin America has a high prevalence of Helicobacter pylori infection and associated diseases, including gastric cancer.

Antibiotic therapy can eradicate the bacterial infection and decrease associated morbidity and mortality.

To tailor recommendations for optimal treatments, Dr Constanza Camargo and colleagues from Maryland, USA summarized published literature and calculated region- and country-specific prevalences of antibiotic resistance.

Searches of PubMed and regional databases for observational studies evaluating Helicobacter pylori antibiotic resistance yielded a total of 59 independent studies published up to 2013 regarding H. pylori isolates collected between 1988 and 2011.

Study-specific prevalences of primary resistance to commonly prescribed antibiotics were summarized using random-effects models.

Between-study heterogeneity was assessed by meta-regression.

Prevalence of antimicrobial primary resistance was 53% for metronidazole
American Journal of Gastroenterology

As a sensitivity analysis, the researchers extended their research to studies of patients with prior Helicobacter pylori-eradication therapy.

Summary prevalences of antimicrobial primary resistance among adults varied by antibiotic, including 12% for clarithromycin, 53% for metronidazole, 4% for amoxicillin, 6% for tetracycline, 3% for furazolidone, 15% for fluoroquinolones, and 8% for dual clarithromycin and metronidazole.

The team found that resistance prevalence varied significantly by country, but not by year of sample collection.

The researchers noted that analyses including studies of patients with prior therapy yielded similar estimates.

Pediatric reports were too few to be summarized by meta-analysis.

Dr Camargo's team concludes, "Resistance to first-line anti-Helicobacter pylori antibiotics is high in Latin American populations."

"In some countries, the empirical use of clarithromycin without susceptibility testing may not be appropriate."

"These findings stress the need for appropriate surveillance programs, improved antimicrobial regulations, and increased public awareness."

Am J Gastroenterol 2014; 109:485495
11 April 2014

Go to top of page Email this page Email this page to a colleague

 26 July 2016 
Post-infectious IBS after C. diff
 26 July 2016 
Neighborhood variation in the use of laparoscopy for colon cancer
 26 July 2016 
Gut microbiota and IBD
 25 July 2016 
Steroids in eosinophilic esophagitis
 25 July 2016 
Prevention of post-ERCP pancreatitis
 25 July 2016 
Antibiotic prophylaxis for open colectomies
 22 July 2016 
Duodenal villous atrophy and celiac disease
 22 July 2016 
Fecal calprotectin and IBD
 22 July 2016 
Upper GI lesions at primary diagnosis in IBD
 21 July 2016 
Radiofrequency ablation in Barrett's
 21 July 2016 
HCV eradication and inflammation in cirrhotic patients
 21 July 2016 
Surveillance of Barrett's
 20 July 2016 
Nonselective β-blockers and survival in cirrhosis
 20 July 2016 
Adolescent body mass index and and colorectal cancer risk
 20 July 2016 
Genetic biomarkers and IBD treatment response
 19 July 2016 
Prevention of chemotherapy-induced nausea and vomiting
 19 July 2016 
Screening diabetic patients for NAFLD
 19 July 2016 
Longterm clinical follow-up of living liver donors
 18 July 2016 
Rectal neuroendocrine tumors
 18 July 2016 
Liver stiffness measurement in chronic liver disease
 18 July 2016 
Liver cancer prediction scores in Hep B
 15 July 2016 
Patient reported outcomes in celiac disease
 15 July 2016 
Tonsillectomy and IBD risk
 15 July 2016 
Trainee IBD education in the USA
 14 July 2016 
Screening for familial pancreatic cancer
 14 July 2016 
Fecal calprotection for IBD prognosis
 14 July 2016 
Perianal surgery risk in Crohn's
 13 July 2016 
Psychological comorbidity and postinfectious IBS
 13 July 2016 
Lung transplant outcomes in Hep C
 13 July 2016 
Graft selection strategy in living donor liver transplants
 12 July 2016 
Therapy for iron deficiency anemia in IBD
 12 July 2016 
Surveillance endoscopy in Barrett's esophagus
 12 July 2016 
Treatment of pediatric acute liver failure
 11 July 2016 
Transition to adulthood in celiac disease
 11 July 2016 
Disturbed sleep and IBS
 11 July 2016 
Factors that influence access to liver transplant
 08 July 2016 
Mortality and peptic ulcers
 08 July 2016 
Statins and cirrhosis in Hep B
 08 July 2016 
Genetic risk score and body mass index
 07 July 2016 
Predicting food triggers in eosinophilic esophagitis
 07 July 2016 
Predictors fecal transplant failure in C. diff infection
 07 July 2016 
Extraperitoneal vs transperitoneal colostomy for hernia
 06 July 2016 
Therapies for Hep B cure
 06 July 2016 
Hospital volume and liver cancer survival
 06 July 2016 
Adverse events after outpatient colonoscopy
 05 July 2016 
Colorectal surgery and dialysis
 05 July 2016 
Non-invasive scoring systems for fibrosis in NAFLD
 05 July 2016 
Exercise and gastroesophageal reflux
 04 July 2016 
Guidelines on PPI and NSAID prescription
 04 July 2016 
Rectal cancer surgery checklist
 04 July 2016 
Autoimmunity in eosinophilic esophagitis and families
 01 July 2016 
Outcome measures in celiac disease
 01 July 2016 
Growth factor activity and IBD
 01 July 2016 
Aspirin and colorectal cancer
 30 June 2016 
Staging system for familial adenomatous polyposis
 30 June 2016 
Antibiotics in children and obesity
 30 June 2016 
IBS-type symptoms in pediatric IBD
 29 June 2016 
Hep C eradication in people who inject drugs
 29 June 2016 
Anti-tumor necrosis factor in mothers and newborns
 29 June 2016 
Progression to esophageal carcinoma in Barrett's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us